Latus Therapeutics Limited, founded in 2019, is a leading research and experimental development biotech company with a vision to find a cure for cancer. We are specifically looking at the B-cell Lymphomas in order to get a better understanding of the underlying signalling mechanism of the cell and its potential in helping people to combat cancer.
Today, in response to the public health crisis, Latus Therapeutics has refocused its efforts to originate not for profit initiative to find a treatment for the patients tested positive with the COVID-19. At a time when thousands of people around the world are dying every day from the disease and economies are paralysed, this crucial research will utilise existing medicines that have already been shown to prevent the virus from infecting human cells in vitro. More information about the trials can be found on our website. Latus' team is contributing their time for free.
Founder - SPIKE trials
Managing Director of the
Dr. Suzie Anthony
Clinical Advisor - SPIKE trials
Honorary Senior Clinical Lecturer in Radiology,
Oxford University Hospital